… studies describing the prevalence of VTE and ATE in COVID-19 up to 30 September 2020. …
-analysis aimed to determine the prevalence of VTE and ATE in patients with COVID-19. …

… published observational studies reporting VTE in COVID-19. … : coronavirus, severe acute
respiratory syndrome coronavirus 2, novel coronavirus, nCoV, 2019-CoV, COVID-19, thrombosis…

… These uncontrollable factors in a study‐level analysis should be considered … levels
between patients who developed VTE and those who did not is limited by the lack of patient‐level …

… In addition, meta-regression analysis examined the associations between outcome and
several characteristics which were aggregate and summarized at the level of the study, which in …

… is high, particularly in ICU patients, which should lead to a high level of clinical suspicion
and low … In the present study, we report on the incidence and risk factors of VTE in COVID-19 …

… We also studied the level of D-dimers and their association … In this study we aimed to evaluate
the rate of thromboembolic … of patients with suspected COVID-19. Those patients that were …

… VTE or mortality, we assessed the prevalence and predictors of VTE or mortality in hospitalized
COVID-19 … ICU-attributable VTE had to occur at least 2 hours after start of ICU level care; …

… studies. We found that the overall arterial and venous and thromboembolism rates of COVID-19
… was exempt from Institutional Review Board review since no individual level data were …

… ) pandemic, the incidence of thromboembolism has been … and arterial thromboembolism
among COVID-19 patients … studies based on a high D-dimer level or only in patients with …

… COVID-19 patients, and D-dimer level and renal function were used to guide the standard of
anticoagulation in the ICU. A D-dimer level of >1000 ng/mL is considered to be a level … level …